Onconova Therapeutics to Present at the 30th Annual Roth Conference in March

On March 6, 2018 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), reported that it will present at the 30th Annual Roth conference taking place on March 11-13 at The Ritz Carlton Hotel in Dana Point, California (Press release, Onconova, MAR 6, 2018, View Source [SID1234524458]). The Company’s Chief Medical Officer, Dr. Steven Fruchtman, will present and be available for one-on-one meetings.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Date: Monday, March 12th, 2018

Time: 7:00 am PT

Location: The Ritz Carlton in Dana Point, Salon 6

The presentation will be available here on the Company’s website.